UFLEX Limited has informed the Exchange about Transcript

UFLEX reported FY25 consolidated revenue of ~INR 15,000 crores, up 12.4% YoY, with EBITDA up ~18% to INR 1,900+ crores and a swing to PAT of INR 142 crores from a INR 690 crore loss last year, helped by lower exceptional losses in Egypt/Nigeria. Packaging Films volumes grew 10.4% and the Aseptic Packaging business operated at ~110% capacity utilization, producing 7.87 billion packs. Management guided FY26 revenue growth of ~10% to ~INR 16,700 crores with EBITDA margins of 12.5-13% (target EBITDA ~INR 2,100 crores), and Aseptic volume guidance of 10-10.5 billion packs. Gross debt stood at ~INR 8,100 crores with net debt of ~INR 6,800 crores; the company plans to repay INR 1,175 crores of long-term debt in FY26 while spending ~INR 1,200 crores on capex including the Mexico WPP pet-food project, Egypt Aseptic plant, and Noida recycling facility.